A clinical trial testing hydroxychloroquine, a malaria drug, on patients hospitalized with COVID-19, has started.
The trial, expected to involve 510 patients, is estimated to be completed in July 2021.
Clinical Trial Exploring Hydroxychloroquine Against COVID-19 Enrolls First Patients
An arrangement of hydroxychloroquine pills in Las Vegas, Nev., on April 6, 2020. John Locher/AP Photo
Zachary Stieber
Senior Reporter
|Updated:
Zachary Stieber
Senior Reporter
Zachary Stieber is a senior reporter for The Epoch Times based in Maryland. He covers U.S. and world news. Contact Zachary at [email protected]
Author’s Selected Articles
